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Abstract
Background: The use of tobacco is known to increase the incidence of developing oral cancer by 6 times, while
the additive effect of drinking alcohol further increases the risk leading to higher rate of morbidity and mortality. In
this short communication, we prospectively assessed the effect of tobacco smoking and alcohol drinking in oral
cancer patients on the overall mortality from the disease, as well as the effect of smoking and drinking reduction/
cessation at time of diagnosis on mortality in the same group.
Materials and methods: A cohort, involved 67 male patients who were diagnosed with oral squamous cell
carcinoma, was included in this study. The smoking and drinking habits of this group were recorded, in addition to
reduction/cessation after diagnosis with the disease. Comparisons were made to disease mortality at 3 and 5 years.
Results: Follow-up resulted in a 3-year survival of 46.8% and a 5-year survival of 40.4%. Reduction of tobacco
smoking and smoking cessation led to a significant reduction in mortality at 3 (P < 0.001) and 5 (P < 0.001) years.
Reduction in drinking alcohol and drinking cessation led to a significant reduction in mortality at 3 (P < 0.001) and
5 (P < 0.001) years.
Conclusion: Chronic smoking and drinking does have an adverse effect on patients with oral cancer leading to
increased mortality from cancer-related causes. Reduction/cessation of these habits tends to significantly reduce
mortality in this group of patients. Smoking and drinking cessation counseling should be provided to all newly
diagnosed oral cancer patients.
Introduction
Cancers of the oral cavity and the oro-pharyngeal
region, a subtype of head and neck, continue to be the
6
th most common cancer in the world. They may arise
as a primary disease or as a secondary disease by exten-
sion from regional or distant areas. The most affected
oral sites include the oral tongue, floor of mouth and
buccal mucosa [1-5].
This disease is known to affect more males than
females, and most commonly reported in the elderly
population. The effect of human papilloma virus (HPV)
has led to increase in the reports of oral cancer in
younger population. There are a variety of known histo-
logical subtypes, but squamous cell carcinomas (SCC)
arises in up to 90% of the cases [6-8].
The exact aetiology behind oral cancer is not fully
understood, but mutations at the DNA level usually lead
to activation of certain oncogenes causing abnormal
growth. The most predominant risk factors include
tobacco use and alcohol consumption. These risk factors
may cause or contribute to the formation of oral leukopla-
kia, erthyroplakia, speckled leukoplakia and other abnor-
mal premalignant oral disorders including submucous
fibrosis. Nowadays, the current trends in the spread of
HPV16 have lead in more oral cancer being diagnosed in
non-smokers and non-drinkers [9-11].
The literature is full of case-control and cohort analy-
tic studies establishing a fundamental relationship
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oping oral cancer. Smoking tobacco is known to
increase the incidence of developing oral cancer by 6
times, while the additive effect of drinking alcohol
further increases the risk leading to higher rate of mor-
bidity and mortality [12-23].
Chronic smokers and drinkers are known to succumb
from this disease much faster than non-smokers, non-
drinkers oral cancer patients. Also, chewing betel, paan
and Areca is known to be risk factor as well. Smokeless
tobacco contains nicotine and nitrosamines and is usually
marketed for oral or nasal use; several studies have pro-
vided evidence linking it to oral cancer [12-23].
In this short communication, a small cohort of patients
with oral squamous cell carcinoma (SCC) that underwent
surgical resection for their pathologies were followed up
for a minimum period of 5 years. The aim of this study
was to prospectively assess the effect tobacco and alcohol
c o n s u m p t i o no nm o r t a l i t yf rom this disease; also the
effect of smoking and alcohol reduction/cessation at time
of diagnosis on survival.
Materials and methods
In this prospective study, identical treatment protocols
were used to treat 67 patients with oral SCC referred to
the Department of Oral and Maxillofacial Surgery, Uni-
versity College Hospital, London between 1998 and 2003.
All applications were accompanied by multidisciplinary
team recommendation, ethical approval, and informed
patient consent. The patients’ data were entered onto
proformas, which were validated and checked by interval
sampling. The patients’ data included a range of clinical
and operative variables. Data collection also included
smoking and drinking status, smoking and drinking
reduction/cessation at time of diagnosis, comorbidities,
recurrence, cause of death, date of death, and last clinic
review. The wording “chronic” was used for smokers and
drinkers with an ongoing habit for > 20 years.
Demographics of the patients included in the study are
highlighted in Table 1. The patient population comprised
67 males. Their mean age at the first diagnosis of Oral
SCC was 62.2 years (SD 15.6, min. 25, max. 96 years).
Most of the patients were Caucasians (82.1%); other pro-
minent racial groups included Indians (10.4%) and Mid-
dle-Easterns (4.5%).
Clinical presentation was mostly an ulcer (74.6%) or a
papule (20.9%). Primary sites were mainly identified in
the tongue (40.3%), floor of mouth (FOM, 20.9%), lower
alveolus (11.9%) and buccal mucosa (7.5%).
Tobacco smoking status was categorised into non-smo-
kers (17.9%), ex-smokers (9.0%), and 5 categories of
chronic smokers (i) < 5 cig/day (5.5%), (ii) 5-9 cig/day
(10.9%), (iii) 10-14 cig/day (1.8%), (iv) 15-9 cig/day (1.8%)
and (v) ≥ 20 cig/day (67.3%). Betel nut chewing was
reported by 6 (9.0%) patients. Alcohol drinking status
was categorised into non-drinkers (29.9%), ex-drinkers
(1.5%), and 3 categories of chronic drinkers (i) < 10
units/week (4.3%), (ii) 11-20 units/week (19.1%) and (iii)
> 20 units/week (74.5%). Advice on smoking and drink-
ing and betel nut chewing reduction/cessation was given
to all chronic users prior to surgery and their smoking
and drinking status was followed-up to assess outcome.
Prior to admission, patients were fully staged. Current
staging protocols in our unit requires each patient to
undergo magnetic resonance imaging (MRI) of the head
and neck, ultrasonographic (US) assessment of the neck
nodes, and computed tomography (CT) of the chest and
upper abdomen. Clinical staging showed that 13 patients
had T1N0 disease, while 10 patients had T2N0 disease;
Stage IV tumour was reported in 44 patients (65.7%).
Tumour grading was also carried out and reported prior
to treatment. Pathological analysis revealed that 13
patients had well differentiated SCC, 4 patients with well-
moderately differentiated SCC, 40 patients had moderately
differentiated disease, 5 had moderate-poorly differen-
tiated carcinoma and another 5 patients had poorly differ-
entiated disease. Nearly 60% of the cohort received
postoperative radiotherapy. Each of the patients was fol-
lowed-up for a minimum of 5 years.
Statistical analysis
The outcomes of the categorical clinico-pathological vari-
ables were summarized as frequencies and percentages for
the whole group of patients and the recurrence group.
The numerical variables: ‘age at 1
st diagnosis of SCC’,
‘depth of invasion (mm)’, ‘days in ICU post-treatment’ and
‘days in hospital post-treatment’ were summarized by the
median, minimal, and maximal values. Fisher’se x a c tt e s t
were used to test for statistical significance of the findings,
especially the effect of smoking and drinking reduction/
cessation on survival at 3 and 5 years.
Results
Tumour clearance was definitively achieved in 39 (58.2%)
patients; unfortunately, tumour recurred in 26 patients
and was treated by further resection and/or radiotherapy.
The status of the surgical margins showed non-cohesive
invasion in 34 (50.7%) patients, dysplasia at margin in 19
(28.4%) patients, and presence of severe dysplasia in 33
(49.3%) patients with mean depth of tumour invasion of
1 0 . 0±6 . 5m m( M i n .1 . 2 ,M a x .3 5 . 0 ) .V a s c u l a ri n v a s i o n
was evident in 3 (4.5%) patients, while nerve invasion was
identified only in a patient (Table 1).
The median days of stay in ICU was 1 day while the
median days of stay in hospital was 12 days. Follow-up
resulted in a 3-year survival of 46.8% and a 5-year survival
of 40.4%. The causes of death were either tumour related
(i.e. loco-regional or distant metastasis) or non-tumour
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No. of patients
(%)
No. of patients
(%)
No. of patients
(%)
Age at 1st
presentation
Secondary site
(Cont.)
Tumour
clearance
Mean 62.2 Maxillary tuberosity 1 (1.5) Positive margins 28 (41.8)
Std. Deviation 15.6 Retromolar area 1 (1.5) Negative margins 39 (58.2)
Minimum 24.0 Hard palate 1 (1.5)
Maximum 96.0 Buccal mucosa 5 (7.5) Depth of invasion (mm)
Tonsil 2 (3.0) Median 10.0
ASA Minimum 1.2
I 24 (35.8) Smoking status Maximum 35.0
II 31 (46.3) Non-smoker 12 (17.9)
III 12 (17.9) Ex-smoker 6 (9.0) Dysplasia at margin 19 (28.4)
Chronic Smoker (< 5 cig/day) 3 (5.5)
Ethnicity Chronic Smoker 9 cig/day) (5- 6 (10.9) Presence of severe
dysplasia
33 (49.3)
Caucasian 55 (82.1) Chronic Smoker (10-14 cig/
day)
1 (1.8)
Indian 7 (10.4) Chronic Smoker (15-19 cig/
day)
1 (1.8) Non-cohesive Invasive
front
34 (50.7)
Middleastern 3 (4.5) Chronic Smoker (≥ 20 cig/
day)
37 (67.3)
African 2 (3.0) Vascular invasion 3 (4.5)
Advice on smoking
cessation
Clinical
presentation
Reduction of smoking 12 (21.8) Nerve invasion 1 (1.5)
Ulcer 50 (74.6) Cessation of Smoking 13 (23.6)
Macule 2 (3.0) Bone/cartilage invasion 0 (0.0)
Papule 14 (20.9) Betel nut chewing 6 (9.0)
Nodule 1 (1.5) Days in ICU
Drinking status Median 1
Primary site Non-drinker 20 (29.9) Minimum 0
Lateral tongue 25 (37.3) Ex-drinker 1 (1.5) Maximum 11
FOM 14 (20.9) Chronic drinker (< 10 u/week) 2 (4.3)
Lower alveolus 8 (11.9) Chronic drinker (10-20 u/
week)
9 (19.1) Days in Hospital
Retromolar area 4 (6.0) Chronic drinker (> 20 u/week) 35 (74.5) Median 12
Upper alveolus 4 (6.0) Minimum 1
Dorsal tongue 1 (1.5) Advice on drinking
cessation
Maximum 90
Buccal mucosa 5 (7.5) Alcohol reduction 15 (31.9)
Ventral tongue 1 (1.5) Alcohol cessation 9 (19.1) Post-surgical radiotherapy 40 (59.7)
Lower lip 2 (3.0)
Soft palate 1 (1.5) Tumour staging Recurrence 26 (38.8)
Hard palate 1 (1.5) I 13 (19.4)
Tonsil 1 (1.5) II 10 (14.9) Survived 3 years 22 (46.8)
III 3 (4.5)
Secondary site IV 41 (61.2) Survived 5 years 19 (40.4)
No site 44 (65.7)
Lower alveolus 5 (7.5) Differentiation
Ventral tongue 2 (3.0) Well 13 (19.4)
Soft palate 1 (1.5) Well-moderate 4 (6.0)
FOM 5 (7.5) Moderate 40 (59.7)
Moderate-poor 5 (7.5)
Poor 5 (7.5)
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mately to cardiorespiratory failure).
Advice on tobacco smoking reduction and cessation
showed that 12 chronic smokers reduced their smoking
habits to less than 5 cig/day and 13 chronic smokers
stopped smoking immediately after diagnosis. All six
patients with betel nut chewing habits stopped after
being diagnosed with the disease. Advice on alcohol
drinking reduction and cessation showed that 15 chronic
drinkers reduced their alcohol intake to less than 10
units/week and 9 patients stopped completely after being
diagnosed.
The causes of death of patients according to the smok-
ing, betel nut chewing and drinking status are detailed in
Table 2. The reduction of smoking and/or smoking cessa-
tion lead to significant reduction in mortality at 3 (P <
0.001) and 5 (P < 0.001) years. Also, the reduction in
drinking alcohol and/or drinking cessation lead to signifi-
cant reduction of mortality at 3 (P < 0.001) and 5 (P <
0.001) years.
Discussion and conclusion
At least three quarters of oral cancers could be prevented
by the elimination of tobacco smoking and reduction in
alcohol consumption. The removal of these two risk fac-
tors also reduces the risk of recurrence or second primary
in people with oral cancer. Smoking cessation is associated
with a rapid decline in the risk of oral cancers, with a 50%
reduction in risk within 3 to 5 years [24].
One of the most effective ways of helping patients pre-
vent or reduce the morbidity and mortality effects of oral
cancer is by promoting tobacco and alcohol abandonment.
A need for further promotion of smoking cessation activ-
ities by the health professionals was identified [25]. In par-
ticular, smoking cessation programs are needed to prevent
the increase in mortality from these cancers in many low-
and middle-income countries [26].
Dental and medical practitioners have a unique oppor-
tunity to lead the advancement in this field aiming to
reduce the global effect of oral and oro-pharyngeal and
laryngeal cancers.
Reduction or cessation of smoking soon after diagno-
sis reduced the rate of death significantly (P < 0.001).
The same principle applies for cessation of alcohol
drinking. Chewing betel can be associated with very
poor prognosis and death from loco-regional or distant
metastasis most likely due to a wide spread field effect.
Author details
1UCL Department of Surgery, University College London Medical School,
London, UK.
2Oral and Maxillofacial Surgery Unit, AL-Mustansirya University,
Baghdad, Iraq.
3Leeds Institute of Molecular Medicine, School of Medicine,
University of Leeds, Leeds, UK.
4Department of Otolaryngology/Head and
Neck Surgery, Chase Farm & Barnet NHS Trust, Enfield, UK.
5Head & Neck
Unit, University College London Hospital, London, UK.
6Biostatistics Unit, UCL
Eastman Dental Institute, London, UK.
7Department of Oral Surgery and
Radiology, School of Dentistry, Aristotle University, Thessalonica, Greece.
Authors’ contributions
All authors have contributed intellectually and to the writing of this
manuscript. AP: contributed to the primary analysis of this study and the
results are highlighted in Table 1 of this study. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 11 January 2012 Accepted: 12 March 2012
Published: 12 March 2012
Table 2 Tobacco smoking, betel nut chewing and alcohol drinking vs. mortality at 3 and 5 years.
Category 3-years survival 5-years survival Cause of death
Non-smoker 9/12 8/12 Regional met
Ex-smoker 4/6 3/6 Non-cancer related
Chronic Smoker (< 5 cig/day) 3/3 2/3 Regional met
Chronic Smoker (5-9 cig/day) 2/6 2/6 Regional met
Chronic Smoker (10-14 cig/day) 0/1 0/1 Regional met
Chronic Smoker (15-19 cig/day) 0/1 0/1 Regional met
Chronic Smoker (≥ 20 cig/day) 4/37 (P < 0.001) 4/37 (P < 0.001) Regional and distant met
Reduction of smoking 10/12 (P < 0.001) 9/12 (P < 0.001) Regional and distant met
Cessation of smoking 11/13 (P < 0.001) 10/13 (P < 0.001) Regional and distant met
Betel chewing 2/6 1/6 Regional and distant met
Non-drinker 9/20 9/20 Cancer and non-cancer
Ex-drinker 1/1 1/1 Cancer and non-cancer
Chronic drinker (< 10 u/week) 2/2 2/2 Cancer and non-cancer
Chronic drinker (10-20 u/week) 3/9 4/9 Non-cancer related
Chronic drinker (> 20 u/week) 7/35 3/35 Regional and distant met
Alcohol reduction 10/15 (P < 0.001) 9/15 (P < 0.001) Non-cancer related
Alcohol cessation 8/9 (P < 0.001) 7/9 (P < 0.001) Regional met
Also the effect of smoking and drinking reduction/cessation on the mortality. Causes of death have been identified
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